Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.12 USD | +6.67% | -13.31% | -.--% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 10.00 | 11.31 | 10.09 |
Spread/Res. | -8.80% | -19.36% | -9.61% |
Spread/Supp. | +27.73% | +27.73% | +19.84% |
Support | 7.140 | 7.140 | 7.610 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BOLD Stock
- Charts Boundless Bio, Inc.